RenaClinical can provide IMP importation services into the EU and UK from around the world via our HPRA and MHRA approved facilities.  Our two sites are fully integrated to enable a seamless transition between the EU & UK   

  • QP 3rd Country GMP declarations and auditing to facilitate the importation process

  • QC Importation testing is available

  • Provision of all regulatory documentation relating to IMP importation in support of CTA applications

  • We offer a turn-key solution for clients located outside of the EU that wish to run clinical trials within the EU or UK.  RenaClinical has helped a number of US, Canadian, Australian and Taiwanese-based clients to establish their existing clinical trials within the EU.  These clients range from small biotech startups to large research organisations. 

    Book a FREE QP Consultation now to discuss your importation requirements